Clinical Trial Update: Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the dose-response relationship of fludrocortisone in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Fludrocortisone (Fludrocortisone)

Snippet

Sponsor: The George Institute | Conditions: Critically Ill, Septic Shock | Phase 2 | Status: COMPLETED